| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |